Cheng‐Hsiang Lo

725 total citations
40 papers, 501 citations indexed

About

Cheng‐Hsiang Lo is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Cheng‐Hsiang Lo has authored 40 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Hepatology. Recurrent topics in Cheng‐Hsiang Lo's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Cheng‐Hsiang Lo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Cheng‐Hsiang Lo collaborates with scholars based in Taiwan, United States and Japan. Cheng‐Hsiang Lo's co-authors include Wen‐Yen Huang, Chun‐Shu Lin, Jen-Fu Yang, Yee‐Min Jen, Hsing‐Lung Chao, Meei‐Shyuan Lee, Kuen‐Tze Lin, Wei‐Chou Chang, Chia‐Hung Kao and Cheng‐Li Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Cheng‐Hsiang Lo

37 papers receiving 494 citations

Peers

Cheng‐Hsiang Lo

HEPAT

PRM

SURGE

ONCOL

RNMI

Ji Hyeon Joo South Korea

Su Jung Shim South Korea

Yangkui Gu China

Eleni Gkika Germany

Qiao-Qiao Li China

Takuma Nomiya Japan

Ting‐Shi Su China

M Hamami Germany

James D. Kolker United States

Alexis Bujold Canada

Ji Hyeon Joo South Korea

Cheng‐Hsiang Lo

93 ×0.4

HEPAT

151 ×0.9

PRM

142 ×1.0

SURGE

125 ×1.0

ONCOL

92 ×1.0

RNMI

Citations per year, relative to Cheng‐Hsiang Lo Cheng‐Hsiang Lo (= 1×) peers Ji Hyeon Joo

Countries citing papers authored by Cheng‐Hsiang Lo

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Hsiang Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hsiang Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hsiang Lo more than expected).

Fields of papers citing papers by Cheng‐Hsiang Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hsiang Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hsiang Lo. The network helps show where Cheng‐Hsiang Lo may publish in the future.

Co-authorship network of co-authors of Cheng‐Hsiang Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Hsiang Lo. A scholar is included among the top collaborators of Cheng‐Hsiang Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Hsiang Lo. Cheng‐Hsiang Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Po‐Huang, Cheng‐Hsiang Lo, Yu–Fu Su, et al.. (2025). Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysis. EClinicalMedicine. 87. 103432–103432.

Li, Hsiao-Chi, Wei-Chou Chang, Chao-Cheng Wu, et al.. (2024). Improving the prediction of patient survival with the aid of residual convolutional neural network (ResNet) in colorectal cancer with unresectable liver metastases treated with bevacizumab-based chemotherapy. Cancer Imaging. 24(1). 165–165. 2 indexed citations

Lo, Cheng‐Hsiang, Yu–Fu Su, Jen-Fu Yang, et al.. (2024). Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma. JCO Precision Oncology. 8(8). e2400555–e2400555. 1 indexed citations

Lin, Hsuan‐Hwai, et al.. (2023). Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month. European Journal of Radiology. 170. 111266–111266.

Huang, Wen‐Yen, et al.. (2022). Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology. 52(9). 992–1000. 3 indexed citations

Lin, Chun‐Shu, et al.. (2021). Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series. Radiation Oncology. 16(1). 13 indexed citations

Chang, Wei‐Chou, Hsian‐He Hsu, Wen‐Yen Huang, et al.. (2021). Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (. Journal of Hepatocellular Carcinoma. Volume 8. 937–949. 18 indexed citations

Huang, Wen‐Yen, et al.. (2021). Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 1299–1309. 10 indexed citations

Lo, Cheng‐Hsiang, et al.. (2021). Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. npj Genomic Medicine. 6(1). 40–40. 27 indexed citations

10.

Lo, Cheng‐Hsiang, et al.. (2021). Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer. BMC Cancer. 21(1). 945–945. 5 indexed citations

11.

Tsai, Chiao‐Ling, et al.. (2020). Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy. Liver Cancer. 9(3). 326–337. 14 indexed citations

12.

Yang, Jen-Fu, Cheng‐Hsiang Lo, Meei‐Shyuan Lee, et al.. (2019). Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis. Radiation Oncology. 14(1). 180–180. 27 indexed citations

13.

Lo, Cheng‐Hsiang, Jen-Fu Yang, Yee‐Min Jen, et al.. (2017). Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy. PLoS ONE. 12(5). e0177793–e0177793. 21 indexed citations

14.

Lo, Cheng‐Hsiang, Meei‐Shyuan Lee, Jen-Fu Yang, et al.. (2017). Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 99(1). 145–152. 31 indexed citations

15.

Huang, Wen‐Yen, Chun‐Shu Lin, Yu–Fu Su, et al.. (2017). Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study. PLoS ONE. 12(4). e0175217–e0175217. 21 indexed citations

16.

Lo, Cheng‐Hsiang, et al.. (2014). Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization. European Journal of Gastroenterology & Hepatology. 26(3). 345–352. 20 indexed citations

17.

Lo, Cheng‐Hsiang, Wen‐Yen Huang, Hsing‐Lung Chao, Kuen‐Tze Lin, & Yee‐Min Jen. (2014). Novel application of stereotactic ablative radiotherapy using CyberKnife® for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences. Oncology Letters. 8(1). 355–360. 21 indexed citations

18.

Lo, Cheng‐Hsiang, et al.. (2014). Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 29(11). 1919–1925. 14 indexed citations

19.

Huang, Wen‐Yen, Chia‐Hung Kao, Wen‐Sheng Huang, et al.. (2013). ¹⁸F-FDG PET and Combined ¹⁸F-FDG–Contrast CT Parameters as Predictors of Tumor Control for Hepatocellular Carcinoma After Stereotactic Ablative Radiotherapy. Journal of Nuclear Medicine. 54(10). 1710–1716. 22 indexed citations

20.

Li, Pengfei, et al.. (2013). Pulmonary pleomorphic carcinoma with multiple metastases to the right posterior knee complicated by paraneoplastic hypercalcemia. Oncology Letters. 7(2). 452–454. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact